113. Muscular dystrophy Clinical trials / Disease details

Clinical trials : 622 / Drugs : 485 - (DrugBank : 99) / Drug target genes : 59 - Drug target pathways : 168

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02354352 (ClinicalTrials.gov)	March 20, 2015	27/1/2015	Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy	Therapeutic Potential for Aldosterone Inhibition in Duchenne Muscular Dystrophy	Duchenne Muscular Dystrophy	Drug: Eplerenone;Drug: Spironolactone	Ohio State University	University of California, Los Angeles;University of Utah;University of Colorado, Denver;University of Kansas Medical Center;Vanderbilt University Medical Center	Completed	7 Years	N/A	Male	52	Phase 3	United States
2	NCT01521546 (ClinicalTrials.gov)	February 2012	26/1/2012	Eplerenone for Subclinical Cardiomyopathy in Duchenne Muscular Dystrophy	Early Treatment With Aldosterone Antagonism Attenuates Cardiomyopathy in Duchenne Muscular Dystrophy	Duchenne Muscular Dystrophy	Drug: eplerenone;Drug: placebo	Subha Raman	Ballou Skies	Completed	7 Years	N/A	Male	42	N/A	United States